Funded Tech Companies
Stemline Therapeutics
Stemline Therapeutics, operating out of New York, received investment capital from private investors and FirstMark Capital.
Company Overview
Company Name
Stemline Therapeutics
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
750 Lexington Ave. 11th Floor
New York, NY 10022
USA
New York, NY 10022
USA
Phone
Website
Email Address
Company Background Information
Overview
Stemline Therapeutics, Inc. (NASDAQ: STML) is a clinical stage biotechnology company developing oncology compounds directed to cancer stem cell targets. Stemline's lead compound, SL-401, targets the interleukin-3 receptor present on multiple hematological cancers including leukemia and leukemia cancer stem cells.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
1/29/2013
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ivan Bergstein
Chief Operating Officer
Kenneth Hoberman
VP - Finance
David Gionco
Company Investors
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
Our data comes from VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs